Controversy Over Efficacy
There is disagreement about whether this therapy benefits patients. Many insurers refuse to cover the treatment. Several literature reviews by insurers conclude that there is no evidence of efficacy.
A number of investigators have found no physiologic benefit from pulsatile delivery.
In some cases, insurance companies have been ordered to pay for that patient. For example, a trial with CalPERS resulted in a decision ordering Blue Cross and other insurance providers to pay for the therapy as to those parties.
Read more about this topic: Pulsatile Insulin
Famous quotes containing the words controversy and/or efficacy:
“Ours was a highly activist administration, with a lot of controversy involved ... but I’m not sure that it would be inconsistent with my own political nature to do it differently if I had it to do all over again.”
—Jimmy Carter (James Earl Carter, Jr.)
“If there is a case for mental events and mental states, it must be that the positing of them, like the positing of molecules, has some indirect systematic efficacy in the development of theory.”
—Willard Van Orman Quine (b. 1908)